Since 1 February 2021 pharmacists have been able to supply certain TGA approved medical cannabis products containing a low dose of cannabidiol over-the-counter.
Beware of buying medicines online.
Products sold on the black market, especially from online sellers that do not request a doctor’s prescription, are unlikely to achieve the desired results and can be very dangerous.
A study published in the Journal of Clinical Pharmacology found that it is common for CBD products to be labelled with inaccurate dosage and that CBD concentration varied across batches of the same product, purchased at different times.
Although drowsiness is not a known side effect of CBD alone, it may occur if the CBD interacts with other medications you may be taking.
Advertising medicines that are not in the Australian Register of Therapeutic Goods is generally prohibited.
For example, any advertising that claims a medicinal cannabis product can treat cancer, mental illness, epilepsy or any other serious condition is likely to be breaking the law, even if the advertiser believes there is evidence to support the claim.
The regulatory scheme is critical to the safety of Australian consumers, and the TGA investigates suspected illegal activity in relation to therapeutic goods, including advertising.
The TGA will review complaints of alleged non-compliant advertising of medicinal cannabis products to the public.